PURA VIDA INVESTMENTS LLC 13D and 13G filings for OncoCyte Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:26 pm Sale | 2024-11-14 | 13G | OncoCyte Corporation OCX | PURA VIDA INVESTMENTS LLC | 616,587 4.570% | -91,585 (-12.93%) | Filing |
| 2024-02-14 5:03 pm Sale | 2023-12-31 | 13G | OncoCyte Corporation OCX | PURA VIDA INVESTMENTS LLC | 708,172 8.450% | -123,919 (-14.89%) | Filing |
| 2023-04-14 4:31 pm Sale | 2023-04-14 | 13G | OncoCyte Corporation OCX | PURA VIDA INVESTMENTS LLC | 832,091 9.990% | -70,723 (-7.83%) | Filing |
| 2023-02-14 1:11 pm Unchanged | 2022-12-31 | 13G | OncoCyte Corporation OCX | PURA VIDA INVESTMENTS LLC | 902,814 15.220% | 0 (Unchanged) | Filing |
| 2023-02-14 11:33 am Purchase | 2022-12-31 | 13G | OncoCyte Corporation OCX | PURA VIDA INVESTMENTS LLC | 902,814 15.220% | 291,616 (+47.71%) | Filing |
| 2021-01-28 3:44 pm Purchase | 2021-01-20 | 13G | OncoCyte Corporation OCX | PURA VIDA INVESTMENTS LLC | 611,198 15.540% | 326,369 (+114.58%) | Filing |